Dynacure
targeting showed dose dependent muscle uptake of and reduction of protein in mouse model | Dynacure
Company
Deck Type
IPO
Deck date
July 2021
Slide
13 of 33
Related slides by other companies
Alkermes
Investor Presentation
March 2023
selective agonist showed dose dependent increased wakefulness and reduced cataplexy in preclinical models | Alkermes
Alkermes
Investor Presentation
January 2023
selective agonist showed dose dependent increased wakefulness and reduced cataplexy in preclinical models | Alkermes
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io